Affymax Announces Upcoming Webcasts and Conference Participation

PALO ALTO, Calif.--(BUSINESS WIRE)-- Affymax, Inc. (NAS: AFFY) today announced the company's participation in the following investors conferences.

  • 24th Annual Piper Jaffray Health Care Conference
    Tuesday, November 27, 2012 in New York City
    10:00 a.m. Eastern Time (7:00 a.m. Pacific Time)
  • 2012 Deutsche Bank dbAccess BioFEST
    Monday, December 3, 2012 in Boston
    2:15 p.m. Eastern Time (11:15 a.m. Pacific Time)

A live webcast of the presentations will be available on the investors section of the Company's website at A replay will also be available for 30 days following the presentations.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses.

The company's first marketed product, OMONTYS® (peginesatide) Injection, was approved by the U.S. Food and Drug Administration (FDA) in March 2012. For additional information, please visit

Affymax, Inc.
Alexandra Santos, 650-812-8961
Associate Director, Corporate Communications

KEYWORDS:   United States  North America  California  Massachusetts  New York


The article Affymax Announces Upcoming Webcasts and Conference Participation originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Increase your money and finance knowledge from home

What Is Your Risk Tolerance?

Answer the question "What type of investor am I?".

View Course »

Behavioral Finance

Why do investors make the decisions that they do?

View Course »